Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

RedPoint Oncology Inc
Profile last edited on: 10/21/2025      CAGE: 9U0Y9      UEI: SHDKHFGJNHT4

Business Identifier: Biotechnology research: eliminating therapy resistant cancers using next-generation payloads for antibody-drug conjugates
Year Founded
----
First Award
2025
Latest Award
2025
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

83 Parker Avenue
Holden, MA 01520
   (520) 301-7818
   N/A
   www.redpointoncology.com
Location: Single
Congr. District: 02
County: Worcester

Public Profile

RedPoint Oncology is a targeted precision oncology company focused on developing next-generation antibody-drug conjugates (ADCs) to create best-in-class therapies for lethal solid tumors that currently have no cure..

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$305,000
Phase II Dollars
$0
Total Awarded
$305,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Mengdie Wang -- Co-Founder and CEO

Company News

There are no news available.